• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • English
    Chinese
    French
    Hindi

    Chronic Kidney Disease Market

    ID: 4289
    110 Pages
    Research Team
    07/2025

    Chronic Kidney Disease Market Research Report Information by Diagnosis (Blood Test, Urine Test, Imaging Test, and Kidney Biopsy), by Treatment (Drugs, Dialysis, and Kidney Transplant) , by Indication (Type 1 Or Type 2 Diabetes, High Blood Pressure, and Polycystic Kidney Disease), by End User (Hospital & Clinics and Diagnostic Centers), by Region (North America, Europe, Asia-Pacific, and Res...

    Share:
    ReportInfographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License

    Market Summary

    Research Methodology on Chronic Kidney Disease Market


    1. Introduction


    This research methodology aims to outline the process of investigating the market for chronic renal disease (CKD). Chronic renal failure (CKD) is a condition in which kidney function gradually deteriorates over time and the disease can cause a range of complications. This report focuses on the market for CKD treatments and the factors driving market growth.


    2. Research Objectives


    The primary objective of this research is to understand the market for CKD treatments and analyze the factors that are contributing to its growth. Specifically, this report will aim to answer the following questions:



    • What are the current drivers of the global CKD market?

    • What is the size of the current market for CKD treatments?

    • What opportunities exist for providers in the CKD market?


    3. Research Design


    The research design employed in this report is qualitative. This is due to the fact that the report is primarily focused on understanding the CKD market, rather than quantitatively measuring the size of the market. Qualitative analysis allows the researcher to gain an understanding of the market through interviews and focus groups with key stakeholders, as well as a review of relevant secondary sources.


    4. Data Collection


    The data collection for this research was conducted through both primary and secondary sources. Primary data was gathered through interviews with key stakeholders in the CKD market, including healthcare providers, manufacturers, and research institutions. Secondary data was obtained from relevant documentation, such as journal articles, white papers, and reports from industry experts.


    5. Data Analysis


    The data collected was analyzed using both qualitative and quantitative techniques. Quantitative analysis was used to assess the size of the CKD market and understand the key drivers and opportunities for market growth. Qualitative analysis was used to gain a deeper understanding of the market through interviews and focus groups with key stakeholders.


    6. Conclusions


    Based on the analysis conducted, it can be concluded that the global CKD market is growing steadily and is likely to continue to do so in the foreseeable future from 2023 to 2030. The key drivers of growth in this market are increased technological advancements, better patient access to treatments, and increased funding for research and development. The market opportunities for providers in the CKD space include the development of innovative treatments and technologies, as well as target pricing and patient education initiatives.

    Market Size & Forecast

    Report Attribute/Metric Details
    Market Size 2023 USD 38.36 billion
    Market Size 2024 USD 40.53 billion
    Market Size 2032 USD 63.52 billion
    Compound Annual Growth Rate (CAGR) 5.78% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Diagnosis, Treatment, Indication, End User, And Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Siemens (Germany), Beckman Coulter (US), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc (US), Nova Biomedical (US), ARKRAY (Japan), AstraZeneca (UK), GlaxoSmithKline Plc (UK), and Bayer AG (Germany)
    Key Market Opportunities New techniques for diagnosis of chronic kidney disease
    Key Market Dynamics Increasing prevalence of kidney diseases Increasing number of biopsy procedures Rising demand for new techniques for diagnosis of chronic diseases.

    Major Players

    Market Segmentation for Chronic Kidney Disease Market

    Chronic Kidney Disease Diagnosis Outlook (USD Billion, 2019-2030)

    • Blood Test

    • Urine Test

    • Imaging Test

    • Kidney Biopsy

    Chronic Kidney Disease Treatment Outlook (USD Billion, 2019-2030)

    • Drugs

    • Dialysis

    • Kidney Transplant

    Chronic Kidney Disease Indication Outlook (USD Billion, 2019-2030)

    • Type 1 Or Type 2 Diabetes

    • High Blood Pressure

    • Polycystic Kidney Disease

    Chronic Kidney Disease End-User Outlook (USD Billion, 2019-2030)

    • Hospital & Clinics

    • Diagnostic Centers

    Chronic Kidney Disease Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • North America Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • North America Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • North America Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • US Outlook (USD Billion, 2019-2030)

      • US Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • US Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • US Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • US Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

    Canada Outlook (USD Billion, 2019-2030)

      • Canada Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Canada Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Canada Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Canada Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Europe Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Europe Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Europe Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Germany Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Germany Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Germany Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • France Outlook (USD Billion, 2019-2030)

      • France Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • France Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • France Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • France Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • UK Outlook (USD Billion, 2019-2030)

      • UK Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • UK Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • UK Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • UK Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Italy Outlook (USD Billion, 2019-2030)

      • Italy Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Italy Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Italy Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Italy Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Spain Outlook (USD Billion, 2019-2030)

      • Spain Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Spain Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Spain Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Spain Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Rest of Europe Outlook (USD Billion, 2019-2030)

      • Rest of Europe Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Rest of Europe Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Rest of Europe Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Rest of Europe Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Asia-Pacific Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Asia-Pacific Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Asia-Pacific Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • China Outlook (USD Billion, 2019-2030)

      • China Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • China Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • China Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • China Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Japan Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Japan Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Japan Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • India Outlook (USD Billion, 2019-2030)

      • India Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • India Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • India Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • India Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Australia Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Australia Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Australia Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • South Korea Outlook (USD Billion, 2019-2030)

      • South Korea Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • South Korea Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • South Korea Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • South Korea Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Rest of Asia-Pacific Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Rest of Asia-Pacific Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Rest of Asia-Pacific Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Rest of the World Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Rest of the World Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Rest of the World Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Middle East Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Middle East Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Middle East Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Africa Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Africa Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Africa Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Chronic Kidney Disease by Diagnosis

        • Blood Test

        • Urine Test

        • Imaging Test

        • Kidney Biopsy

      • Latin America Chronic Kidney Disease by Treatment

        • Drugs

        • Dialysis

        • Kidney Transplant

      • Latin America Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes

        • High Blood Pressure

        • Polycystic Kidney Disease

      • Latin America Chronic Kidney Disease by End-User

        • Hospital & Clinics

        • Diagnostic Centers

    Market Trends

    Global Chronic Kidney Disease Market Overview

    Chronic Kidney Disease Market Size was valued at USD 38.36 Billion in 2023. The Global Chronic Kidney Disease industry is projected to grow from USD 40.53 Billion in 2024 to USD 63.52 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.78% during the forecast period (2024 - 2032).

    The increasing prevalence of kidney diseases, the increasing number of biopsy procedures, and the rising demand for new techniques for diagnosis of chronic diseases are driving the market growth.

    Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

    September 2023: AWAK Technologies (AWAK), an innovative medical technology company that treats end-stage renal disease via dialysis utilizing regeneration technology, announced, that it has raised more than $20 million in Series B funding. This accomplishment not only represents the most substantial fundraising endeavor undertaken by MedTech to date, but also ranks among the most substantial in Southeast Asia as of this moment. The round was co-led by venture capital firms Lion X Ventures and Vickers Venture Partners, Advanced MedTech, Eckuity Capital, a United States-based healthcare venture capital fund, and an investment office specializing in the management of multibillion-dollar assets within the healthcare industry. AWAK PD, an ultraportable and wearable peritoneal dialysis (...

    Market Segment Insights

    Smartphone Sensors Smartphone Type Insights

    The Smartphone Sensors market segmentation, based on smartphone type, includes standard smartphone, rugged smartphone, smartwatches, and other wearable. The standard smartphone segment dominated the market, accounting for the maximum market revenue. A smartphone is a mobile phone with a built-in computer and advanced features, such as web browsing and operating system, which are not associated with its counterpart. The rising mobile internet use, rising disposable income in developing countries, and high ownership of premium design smartphones are a few factors that are anticipated to grow smartphone sales. Smartphones are helped by a mobile operating system that offers advanced computing facilities. A smartphone can also work as a digital media player for uploading photos, videos, and music through a single interface.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035
    Get detailed insights about Chronic Kidney Disease Market

    Smartphone Sensors Manufacturer Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Application Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Regional Insights

    The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

    Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035
    Get detailed insights about Smartphone Sensors Market

    Smartphone Sensors Price Insights

    The Smartphone Sensors market segmentation, based on price, includes USD 300 to USD 500, USD 100 to USD 300, above USD 500, and under USD 100. The USD 300 to USD 500 segment dominated the market revenue in the projected period. Most smartphones sold in medium-end devices have a sensor within this range. For instance: Nubia launched a new flagship Android device powered by the latest Snapdragon 8Gen 2CPU. The OEM has also specified that this gadget, which peculiarly seems to go by the name Z50 even though its processor was the z40 Pro, will compete with the Xiaomi 13 and iQOO11 series with cutting-edge LPDDR5X RAM and storage with the most recent UFS 4.0 spec.

    Get more detailed insights about Chronic Kidney Disease Market

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development to expand their product lines, which will help the Smartphone Sensors market, grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and growing market climate, the Smartphone Sensors industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Smartphone Sensors industry to benefit clients and increase the market sector. In recent years, the Smartphone Sensors industry has offered manufacturers some of the most significant advantages. Major players in the Smartphone Sensors market, including MS AG (Austria), Broadcom Inc. (US), DYNA IMAGE Corporation (China), Murata Electronics Oy (Finland), NEXT Biometrics Group ASA (Norway), Omron Corporation (Japan), Samsung Electronics Co. Ltd. (South Korea), Sony Corporation (Japan)., and others, are attempting to increase market demand by investing in research and development operations.

    Samsung is dedicated to abiding by local laws and regulations and enforcing a strict code of conduct for all employees. Samsung adheres to a straightforward business tent: to usage its technology and expertise to develop top-notch goods and services that make a more cultured world. Samsung provides a high importance on its people and technologies to do this. For Instance: In January 2023, Samsung Electronics launched its new MICRO LED, Neo QLED, and Samsung OLED product lines, along with lifestyle products and accessories, before CES® 2023.

    Apple Inc. is a multinational American technology business with its main office in Cupertino, California. According to revenue, Apple will be the top technological business in the world in 2022, with US $ 394.3 billion in sales. According to market capitalization, Apple is the largest corporation in the world as of March 2023. For Instance: In September 2022, the iPhone 14 and iPhone 14 Plus, which come in two sizes, 6.1 and 6.7 inches and include a smart design, camera upgrades, and game-changing new safety measures, were introduced by Apple. The iPhone 14 and iPhone 14 Plus have a powerful camera system that incorporates the primary and front TrueDepth cameras, the Ultra Wide camera for uncommon perspectives, and the photonic engine, an enhanced picture pipeline.

    Key Companies in the Smartphone Sensors market include

    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)
    MS AG (Austria)

    Industry Developments

    • September 2022: Comcast and Samsung Electronics announced their partnership to create 5G Radio Access Network (RAN) technologies to enhance 5G connection for Xfinity Mobile and Comcast Business Mobile users in Comcast service zones. Samsung will provide 5G RAN technology, and Comcast will deploy Citizens Broadband Radio Service (CBRS) and 600 MHz spectrum to provide 5G access to consumer and business users in the US.
    • October 2022: Huawei announced the release of the newest antenna solutions, including the Maxwell platform and the X2 antenna series, for the subsequent 5G antenna innovation stage. The new technologies speed up 5G deployment by improving antenna and setup capabilities.

    Market Segmentation

    Smartphone Type Outlook

    • Standard Smartphone
    • Rugged Smartphone
    • Smartwatches
    • Other Wearable

    Price Outlook

    • USD 300 to USD 500
    • USD 100 to USD 300
    • Above USD 500
    • Under USD 100

    Manufacturer Outlook

    • Apple Inc.
    • Samsung Electronics
    • Huawei Technology
    • Xiaomi Inc.
    • Oppo
    • Sony Corporation
    • HMD Global

    Application Outlook

    • High-Level
    • Mid-Level
    • Low-Level

    Manufacturer Outlook

    North America
    • US
    • Canada
    Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    Asia-Pacific
    • China
    • Japan
    • India
    • Italy
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    Rest of the World
    • Middle East
    • Africa
    • Latin America

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 38.36 billion
    Market Size 2024 USD 40.53 billion
    Market Size 2032 USD 63.52 billion
    Compound Annual Growth Rate (CAGR) 5.78% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Diagnosis, Treatment, Indication, End User, And Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Siemens (Germany), Beckman Coulter (US), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc (US), Nova Biomedical (US), ARKRAY (Japan), AstraZeneca (UK), GlaxoSmithKline Plc (UK), and Bayer AG (Germany)
    Key Market Opportunities New techniques for diagnosis of chronic kidney disease
    Key Market Dynamics Increasing prevalence of kidney diseases Increasing number of biopsy procedures Rising demand for new techniques for diagnosis of chronic diseases.

    Market Highlights

    Author

    Aarti Dhapte
    Team Lead - Research

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    Q. What is Chronic Kidney Disease?

    Chronic Kidney Disease results in a gradual shutdown of kidney functions.

    Q. What is the CAGR of the Chronic Kidney Disease Market?

    Market is expected to exhibit a strong 5.2% CAGR over the forecast period from 2017 to 2023.

    Q. What is the major driver for the market?

    Increasing prevalence of diabetes is a major driver for the Chronic Kidney Disease Market.

    Q. Which is the leading regional market?

    Asia Pacific is the fastest growing regional market due to the growing prevalence of diabetes in the region.

    Q. What are the leading Chronic Kidney Disease Market players?

    Leading players in the Chronic Kidney Disease Market include Sysmex, Siemens, and Abbott, among others.

    Market Segmentation for Chronic Kidney Disease Market

    Chronic Kidney Disease Diagnosis Outlook (USD Billion, 2019-2030)

    • Blood Test
    • Urine Test
    • Imaging Test
    • Kidney Biopsy

    Chronic Kidney Disease Treatment Outlook (USD Billion, 2019-2030)

    • Drugs
    • Dialysis
    • Kidney Transplant

    Chronic Kidney Disease Indication Outlook (USD Billion, 2019-2030)

    • Type 1 Or Type 2 Diabetes
    • High Blood Pressure
    • Polycystic Kidney Disease

    Chronic Kidney Disease End-User Outlook (USD Billion, 2019-2030)

    • Hospital & Clinics
    • Diagnostic Centers

    Chronic Kidney Disease Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • North America Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • North America Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • North America Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • US Outlook (USD Billion, 2019-2030)

      • US Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • US Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • US Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • US Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

    Canada Outlook (USD Billion, 2019-2030)

      • Canada Chronic Kidney Disease by Diagnosis

        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Canada Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant

      • Canada Chronic Kidney Disease by Indication

        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Canada Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Europe Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Europe Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Europe Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Germany Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Germany Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Germany Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • France Outlook (USD Billion, 2019-2030)

      • France Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • France Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • France Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • France Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • UK Outlook (USD Billion, 2019-2030)

      • UK Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • UK Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • UK Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • UK Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Italy Outlook (USD Billion, 2019-2030)

      • Italy Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Italy Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Italy Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Italy Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Spain Outlook (USD Billion, 2019-2030)

      • Spain Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Spain Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Spain Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Spain Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Rest of Europe Outlook (USD Billion, 2019-2030)

      • Rest of Europe Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Rest of Europe Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Rest of Europe Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Rest of Europe Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Asia-Pacific Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Asia-Pacific Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Asia-Pacific Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • China Outlook (USD Billion, 2019-2030)

      • China Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • China Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • China Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • China Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Japan Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Japan Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Japan Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • India Outlook (USD Billion, 2019-2030)

      • India Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • India Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • India Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • India Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Australia Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Australia Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Australia Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • South Korea Outlook (USD Billion, 2019-2030)

      • South Korea Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • South Korea Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • South Korea Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • South Korea Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Rest of Asia-Pacific Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Rest of Asia-Pacific Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Rest of Asia-Pacific Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Rest of the World Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Rest of the World Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Rest of the World Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Middle East Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Middle East Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Middle East Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Africa Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Africa Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Africa Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers

      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Chronic Kidney Disease by Diagnosis
        • Blood Test
        • Urine Test
        • Imaging Test
        • Kidney Biopsy
      • Latin America Chronic Kidney Disease by Treatment
        • Drugs
        • Dialysis
        • Kidney Transplant
      • Latin America Chronic Kidney Disease by Indication
        • Type 1 Or Type 2 Diabetes
        • High Blood Pressure
        • Polycystic Kidney Disease
      • Latin America Chronic Kidney Disease by End-User
        • Hospital & Clinics
        • Diagnostic Centers
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Global Reports
    Regional Reports
    Country Reports

    Customer Strories

    Watch Video

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Jongwon Byun

    Director, Research Operations
    Case Study

    Smartphone Motherboard Parts Manufacturing Research

    Smartphone Motherboard Parts Manufacturing Research